Pierre Legault
CIK: 0001391045
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
About Legault Pierre
Legault Pierre (SEC CIK 0001391045) files insider reports with the SEC as Director of Syndax Pharmaceuticals Inc (SNDX) and Director of BICYCLE THERAPEUTICS PLC (BCYC).
Signal8 holds 3 ownership filings by Legault Pierre, all Form 4s, filed between Jan 6, 2025 and Feb 6, 2026. Those filings report 3 transactions, from Jan 2, 2025 to Feb 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Legault Pierre's filings is in NEW YORK, NY.
Recent filings by Legault Pierre
Other insiders filing for Syndax Pharmaceuticals Inc (SNDX)
- Podlesak Dennis, Director
- Metzger Michael A, Chief Executive Officer
- Botwood Nicholas A.J., Head of R&D, CMO
- Goldan Keith A., Chief Financial Officer
- Jarrett Jennifer, Director
- Huber Martin H. Jr., Director